Kai-Ze Wu1, Ze-Han Huang1, Zhi-An Zhong1, Hong-Tao Liao1, Yi Zhou1, Bing-Zheng Luo1, Mahesh Anantha-Narayanan2, Rami N Khouzam3, Aakash Garg4, Vladan Vukcevic5, Nicholas G Kounis6, Bin Zhang1. 1. Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510100, China. 2. Division of Cardiovascular Disease, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. 3. Division of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA. 4. Division of Cardiology, Newark Beth Israel Medical Center, Newark, NJ, USA. 5. Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia. 6. Department of Cardiology, University of Patras Medical School, Patras, Rion, Achaia, Greece.
Abstract
BACKGROUND: Data regarding outcomes of percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) is still limited. Our aim was to evaluate clinical outcomes in patients after successful CTO PCI when compared to patients with failed PCI. METHODS: The cohort study enrolled 145 eligible patients with attempted PCI of CTO. Detailed baseline clinical and procedural data, and in-hospital complications were analyzed. The primary end point was occurrence of major adverse cardiac events (MACE). RESULTS: Median follow-up was 11.49±2.01 months. Successful revascularization was associated with a significantly lower 1-year MACE compared to failed revascularization [hazard ratio (HR): 0.026; 95% confidence interval (CI): 0.004-0.176; P=0.0002]. A J-CTO score of ≥3 was associated with a significantly higher 1-year MACE compared with a J-CTO score of <3 in patients undergoing PCI (HR: 4.819; 95% CI: 1.463-15.870; P=0.0097). Moreover, in patients with a J-CTO score ≥3, success of CTO PCI was associated with significantly lower risk of 1-year MACE than failure of CTO revascularization (HR: 0.114; 95% CI: 0.023-0.569; P=0.0081). Multivariate analysis identified the J-CTO score (HR: 2.10; 95% CI: 1.09-4.04; P=0.026) as a positive predictor, and the success of CTO PCI (HR: 0.17; 95% CI: 0.05-0.59; P=0.005) as a negative significant independent predictor of MACEs. CONCLUSIONS: Among patients with CTOs, high J-CTO score was independently associated with worse clinical outcomes. Furthermore, successful PCI was associated with a lower risk of midterm MACE compared with failed revascularization of CTOs.
BACKGROUND: Data regarding outcomes of percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) is still limited. Our aim was to evaluate clinical outcomes in patients after successful CTO PCI when compared to patients with failed PCI. METHODS: The cohort study enrolled 145 eligible patients with attempted PCI of CTO. Detailed baseline clinical and procedural data, and in-hospital complications were analyzed. The primary end point was occurrence of major adverse cardiac events (MACE). RESULTS: Median follow-up was 11.49±2.01 months. Successful revascularization was associated with a significantly lower 1-year MACE compared to failed revascularization [hazard ratio (HR): 0.026; 95% confidence interval (CI): 0.004-0.176; P=0.0002]. A J-CTO score of ≥3 was associated with a significantly higher 1-year MACE compared with a J-CTO score of <3 in patients undergoing PCI (HR: 4.819; 95% CI: 1.463-15.870; P=0.0097). Moreover, in patients with a J-CTO score ≥3, success of CTO PCI was associated with significantly lower risk of 1-year MACE than failure of CTO revascularization (HR: 0.114; 95% CI: 0.023-0.569; P=0.0081). Multivariate analysis identified the J-CTO score (HR: 2.10; 95% CI: 1.09-4.04; P=0.026) as a positive predictor, and the success of CTO PCI (HR: 0.17; 95% CI: 0.05-0.59; P=0.005) as a negative significant independent predictor of MACEs. CONCLUSIONS: Among patients with CTOs, high J-CTO score was independently associated with worse clinical outcomes. Furthermore, successful PCI was associated with a lower risk of midterm MACE compared with failed revascularization of CTOs.
Entities:
Keywords:
Chronic total occlusion (CTO); difficulty grading tool; major adverse cardiovascular event; percutaneous coronary intervention (PCI)
Authors: Roxana Mehran; Bimmer E Claessen; Cosmo Godino; George D Dangas; Kotaro Obunai; Sunil Kanwal; Mauro Carlino; José P S Henriques; Carlo Di Mario; Young-Hak Kim; Seung-Jung Park; Gregg W Stone; Martin B Leon; Jeffrey W Moses; Antonio Colombo Journal: JACC Cardiovasc Interv Date: 2011-09 Impact factor: 11.195
Authors: Paul Fefer; Merril L Knudtson; Asim N Cheema; P Diane Galbraith; Azriel B Osherov; Sergey Yalonetsky; Sharon Gannot; Michelle Samuel; Max Weisbrod; Daniel Bierstone; John D Sparkes; Graham A Wright; Bradley H Strauss Journal: J Am Coll Cardiol Date: 2012-03-13 Impact factor: 24.094
Authors: Giampaolo Niccoli; Francesco De Felice; Flavia Belloni; Rosario Fiorilli; Nicola Cosentino; Francesco Fracassi; Leonardo Cataneo; Francesco Burzotta; Carlo Trani; Italo Porto; Antonio Maria Leone; Carmine Musto; Roberto Violini; Filippo Crea Journal: Am J Cardiol Date: 2012-06-19 Impact factor: 2.778
Authors: Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; P Gabriel Steg; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick W Serruys Journal: Circulation Date: 2007-05-01 Impact factor: 29.690
Authors: Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart Journal: EuroIntervention Date: 2012-05-15 Impact factor: 6.534
Authors: Sudhakar George; James Cockburn; Tim C Clayton; Peter Ludman; James Cotton; James Spratt; Simon Redwood; Mark de Belder; Adam de Belder; Jonathan Hill; Angela Hoye; Nick Palmer; Sudhir Rathore; Anthony Gershlick; Carlo Di Mario; David Hildick-Smith Journal: J Am Coll Cardiol Date: 2014-07-22 Impact factor: 24.094